Haleon plc
HLN
Classement en actions
#13682
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Prix de l'action
$5.01
Capitalisation boursière
$440.81M
Changement (1 jour)
0.13%
Changement (1 an)
6.41%
Pays
GB
Échange Haleon plc (HLN)
Catégorie
Healthcare
Historique du prix de l'action pour Haleon plc (HLN)
Prix de clôture le plus élevé : $4.68 le 2026-10-01
Prix de clôture le plus bas : $3.48 le 2022-07-01
Prix de clôture le plus bas : $3.48 le 2022-07-01
Historique du prix de l'action de Haleon plc de 2022 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -0.76% |
| 2025 | 2.79% |
| 2024 | 16.19% |
| 2023 | 13.23% |
| 2022 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.49 | 20.77% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $222.20 | 29.76% |
CH
|
|
| $18.51 | -3.62% |
IN
|
